Aurora Cannabis Inc. said shareholders who took part in its Aug. 7 annual general meeting by webcast and proxy supported the company's board nominees, the appointment of auditors and its advisory vote on executive compensation.
Meeting turnout and voting results
According to the filing released by the company, a total of 16,639,306 common shares were represented at the meeting, equal to 26.86% of Aurora's issued and outstanding common shares as of the record date.
- Board support: Each of the five director nominees named in the company's disclosure received shareholder approval, with between 85.12% and 86.52% of votes cast in favour.
- Auditor appointment: Shareholders approved the reappointment of Ernst & Young LLP as the company auditor for the coming year.
- Say-on-pay: The company's advisory vote on executive compensation passed with 82.97% of votes in favour.
| Nominee | Votes For | % For | Votes Withheld | % Withheld |
|---|---|---|---|---|
| Miguel Martin | 5,076,096 | 85.12% | 887,633 | 14.88% |
| Michael Singer | 5,148,795 | 86.34% | 814,934 | 13.66% |
| Chitwant Kohli | 5,134,736 | 86.10% | 828,993 | 13.90% |
| Norma Beauchamp | 5,159,834 | 86.52% | 803,895 | 13.48% |
| Rajesh Uttamchandani | 5,127,871 | 85.98% | 835,857 | 14.02% |
Company statement and next steps
In a statement accompanying the voting results, Aurora’s executive chairman and chief executive officer, Miguel Martin, said the outcome reflected shareholder confidence in the board and the company’s direction. He was quoted as saying:
"We're pleased by the support received from our shareholders at this year's meeting. These results demonstrate confidence in our Board of Directors and allow us to remain focused on executing our medical-first strategy, strengthening our global medical cannabis business, and delivering long-term value for shareholders."
The company also said a detailed report of voting results on all resolutions will be filed under its profile on SEDAR+ (www.sedarplus.ca).
What this means locally
For residents and investors in Aurora and across Ontario, the meeting results offer a snapshot of shareholder backing for management priorities. The strong support for the advisory vote on executive compensation — commonly referred to as "say-on-pay" — indicates a majority of participating shareholders approved the company's approach to executive remuneration.
Approval of the auditor and the board slate clears the way for the company to proceed with its stated operational and strategic plans over the coming year. The company noted its focus on a "medical-first" strategy and on international medical markets.
Context and caution
Turnout at the meeting represented just over a quarter of the outstanding common shares. That means while votes cast favoured the resolutions, a large portion of the register did not participate in the meeting. Investors and market observers often look at both participation rates and margin of support when assessing the strength of shareholder endorsement.
Shareholders who want full details of all items voted on at the meeting can consult Aurora's filings on SEDAR+ for the complete voting report and any further disclosure the company provides about its strategic priorities and governance plans.
As the company moves forward under the approved governance structure, local stakeholders — including medical patients, community partners and investors in Ontario — will be watching updates on execution of Aurora's declared medical focus and any operational announcements filed with securities regulators.
Further information about the meeting and the company's disclosures will be publicly available on SEDAR+ and through Aurora's investor relations channels.
